GLSI Stock Analysis and Clinical Breakdown By An Oncologist and Clinical Research Team - a podcast by DSCS Sweat Equity & Investments, LLC dba DSCS CRO

GLSI Stock Analysis and Clinical Breakdown By An Oncologist and Clinical Research Team: In this episode the team analyzes Greenwich Lifesciences meteoric stock rise and discuss the clinical aspects of the GP2 investigational product

Further episodes of The Clinical Research Circle

Further podcasts by DSCS Sweat Equity & Investments, LLC dba DSCS CRO

Website of DSCS Sweat Equity & Investments, LLC dba DSCS CRO